Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,812,971
+$116,798 QoQ
Shares Held
11,076
+0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#2,042
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Meridian Wealth Advisors, LLC holds $18,785,727 across 8 Drug Manufacturers - General names. JNJ ranks #4 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,304 | $7,561,207 | |
| 2 | MRK |
Merck & Co., Inc.
|
25,697 | $3,302,064 | |
| 3 | AMGN |
Amgen Inc
|
8,375 | $3,032,755 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
11,076 | $2,812,971 | |
| 5 | PFE |
Pfizer Inc
|
42,564 | $1,024,941 | |
| 6 | NVS |
Novartis AG
|
2,601 | $407,628 | |
| 7 | ABBV |
AbbVie Inc.
|
1,502 | $377,963 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,107 | $266,198 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,812,971 | 11,076 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,696,173 | 11,030 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,281,002 | 11,022 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,920,951 | 10,360 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,576,532 | 10,321 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,846,794 | 11,136 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,683,666 | 11,642 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,072,747 | 12,790 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $2,114,642 | 14,468 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,251,676 | 14,234 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,325,708 | 14,838 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,332,979 | 14,979 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,505,310 | 15,136 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $2,759,000 | 17,800 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $3,159,385 | 17,885 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $2,943,583 | 18,019 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $3,200,682 | 18,031 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $2,829,831 | 15,967 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,341,606 | 13,688 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,223,209 | 13,766 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,284,284 | 13,866 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,833,652 | 11,157 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,609,997 | 10,230 | Shares | Sole | 2021-05-07 | |
| 2020-09-30 | $1,609,243 | 10,809 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,376,908 | 9,791 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,397,845 | 10,660 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||